People’s Pharmacy: The FDA issues update on breast implant illness
Q. Allergan ran a long-term study on silicone breast implants in 2009. I always wanted a more feminine body like the girls in the magazines, so I joined and got implants. They never followed up with ...
AbbVie Appears Ready To Move Higher
AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...
Future Market Insights3d
Extremity Tissue Expanders Market Dominated by Key Players, Accounting for 60% of Global Share
Top five players, including Mentor Worldwide LLC and Allergan PLC, control 60% of the extremity tissue expanders market.
Hosted on MSN3d
2019 to 2020 Saw 17.9 Percent Decrease in Ophthalmic Procedures in Seniors
There was a notable decrease in common ophthalmic procedures among Medicare beneficiaries during the first year of the ...
Natrelle Returns to Demystify Breast Reconstruction With Unique, Inspiring Stories in New Campaign That Celebrates ‘Every Curve, Every Shape’
Casting is open. Allergan Aesthetics is on the search for women to inspire women as one of the Faces of Natrelle. The ...
globalcosmeticsnews4d
Allergan Aesthetics Introduces New AMI Training Centers Across the US
Allergan Aesthetics, an AbbVie company, has unveiled plans to open three new Allergan Medical Institute (AMI) Training ...
People’s Pharmacy: Here’s the latest FDA update on breast implant illness
The safety of breast implants has been controversial for decades. On February 6, 2025, the Food and Drug Administration ...